CE1682 Oral Cancer

From Early Detection to Treatment and Quality of Life

Dolphine Oda, BDS, MS and Eric Statler

lecture icon Lecture

This course is offered in partnership with the Oregon Health Sciences University Office of Continuing Dental Education. Registration will be through OHSU CDE – click here.

Course Description

This is a patient-clinician interactive course in which a patient’s personal experiences in dealing with stage four oral cancer will greatly enrich clinician learning about both patient experience and the clinician’s role in the early recognition of such malignancies. The powerful personal story of Eric Statler’s courageous battle with his own oral cancer will depict most poignantly the importance of clinicians doing all they can to recognize this serious, but often treatable, disease as close as possible to its inception. Unfortunately, prompt recognition and early treatment are critical goals that do not always become realities, as clinicians will come to understand as Eric describes his experiences with his symptoms and diagnosis, and then with treatments including surgery, radiation and chemotherapy. He will describe his experience as a patient living those treatments and their side effects, both short and long term. Eric will also discuss how dental clinicians can be involved in increasing the quality of life for the oral cancer patients.

This lecture will integrate the patient’s experience with the clinician’s role in obtaining a history, examining the patient, and deciding upon a course of diagnostic action. Dr. Dolphine Oda, in describing the role of the clinician, will present information regarding the range of clinical presentations of oral cancer, focusing on strategies for early detection. She will describe the clinical presentations of oral red and white lesions from their benign early stages through their progression to squamous cell carcinoma, the disease that impacted Eric’s life and changed him immensely. Dr. Oda will go on to discuss etiology-based oral cancers in terms of their clinical presentations, differentiating among tobacco-induced, HPV-associated, and lichen planus-associated oral SCC patient profiles. She will then describe oral conditions that may mimic cancer but are otherwise benign. Such conditions include immune-mediated diseases like lichen planus/lichenoid mucositis, and mucous membrane pemphigoid. All of the conditions discussed in this course are both common and important for dental professionals to be able to recognize. These topics will be discussed in a concise and clear manner, giving dental practitioners information that they can use in their daily practice.

Course Objectives

As a result of attending this course, you will have an understanding of:

  • Early red and white lesions that may progress to malignancy
  • The clinical presentation of tobacco-induced & HPV-associated oral SCC
  • Which lesions to biopsy and which to observe – why and how often
  • The most common oral chronic immune diseases
  • The potential of oral lichen planus for transformation
  • Various types of stage-related oral cancer treatments
  • The side effects of the different treatments modalities
  • Developing an improved strategy of dental care for patients with oral cancer
  • The role of nutrition and hydration in the cancer fight with oral cancer patients

Instructors

Dolphine OdaDolphine Oda is Professor of Oral Pathology in the Department of Oral and Maxillofacial Surgery at the School of Dentistry, University of Washington, and the Director of the UW’s Oral Pathology Biopsy Service. Dr. Oda is on the medical staff at the University of Washington Medical Center and Harborview Medical Center. In 2013, she was awarded a lifetime achievement award by the Oral Cancer Foundation for over 30 years of service to oral cancer patients. In 2009, she was awarded the Distinguished Teaching Award, the UW’s highest honor for outstanding teaching, and has been awarded an additional 30 teaching awards within the School of Dentistry. Dr. Oda’s research interests include molecular changes in oral carcinogenesis and HPV and oral cancer. She has over 70 papers published in refereed journals and publishes a popular monthly column called Case of the Month. Dr. Oda is a Diplomate of the American Board of Oral and Maxillofacial Pathology and holds a Washington State dental license. She is also a member of the American Academy of Oral and Maxillofacial Pathology, the International Association of Oral Pathologists, and USCAP.

Eric Statler is a self-made entrepreneur, customer service expert, and family man from North Central Idaho, whose victory over Stage IV Oral Cancer inspired him to use his talents to help others facing the disease. He has served as a patient advocate, Director of Strategic Partnerships for the Oral Cancer Foundation, organized awareness/screening campaigns nationally, and developed relationships with a number of the top dental and oral medicine programs in the country.

Course Logistics

DATE:
Friday, May 5, 2017

LOCATION:
Clark College at Columbia Tech Center
18700 SE Mill Plain Blvd
Vancouver, WA 98683

TARGET AUDIENCE:
This course is designed for specialists, dentists, hygienists and dental assistants.

REGISTER:
Registration will be through the OHSU Office of CDE. Click here.

TIMES:
Registration and Continental Breakfast: 8:00am – 8:30am
Course: 8:30am – 3:30pm

TUITION:
Early Bird until March 24, 2017
$251/Dentist
$161/Staff
$226/Current Dental Alumni Member

Until May 3, 2017 (after, $25 more)
$279/Dentist
$179/Staff
$251/Current Dental Alumni Member

CREDITS:
7 hours


ada cerp logo

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Washington and Oregon Health Sciences University.

acde logo

The University of Washington and Oregon Health Sciences University are members of the Association for Continuing Dental Education.

The University of Washington and Oregon Health Sciences University designate this activity for 7 continuing education credits.